Search This Blog

Tuesday, April 14, 2020

Iovance up before data presentation on TIL therapy in lung cancer

Iovance Biotherapeutics (IOVA +19.1%) is up, albeit on average volume, ahead of Phase 1 data on the use of tumor infiltrating lymphocytes (TIL) in patients with non-small cell lung cancer (NSCLC). The results will be presented on Wednesday, April 28, at the American Association for Cancer Research Virtual Annual Meeting.
The title tips the outcome: Durable complete responses to adoptive cell transfer using [TIL] in non-small cell lung cancer: a phase I trial.
The company’s core technology is TIL.
https://seekingalpha.com/news/3560606-iovance-bio-up-19-ahead-of-data-presentation-on-til-therapy-in-lung-cancer

NuVasive sees decline in Q1 revenue, pulls guidance in response to pandemic

On a preliminary basis, NuVasive (NASDAQ:NUVA) expects Q1 revenue of $259M – 261M, down over 5% (midpoint) from a year ago and more than 14% shy of ~$280M consensus due to COVID-19 headwinds on elective surgical procedures.
2020 guidance withdrawn and temporary cost-cutting measures implemented.
At the end of March, it had more than $500M in cash and $550M available under its credit revolver.
Management will release final results on May 6.
https://seekingalpha.com/news/3560652-nuvasive-sees-decline-in-q1-revenue-pulls-guidance-in-response-to-pandemic

Illumina pulls guidance amid COVID-19 disruptions

On a preliminary basis, Illumina (NASDAQ:ILMN) expects Q1 revenue of ~$858M, up a little over 1% from a year ago and about 2% above consensus of ~$842M.
The company expects a significant negative impact in Q2 due to COVID-19.
2020 guidance withdrawn.
Final results will be released on Thursday, April 30, after the close.
Shares down 1% after hours.
https://seekingalpha.com/news/3560656-illumina-pulls-guidance-amid-covidminus-19-disruptions

Procter & Gamble increases dividend by 6%

Procter & Gamble (NYSE:PG) declares $0.7907/share quarterly dividend, 6% increase from prior dividend of $0.7459.
Payable May 15; for shareholders of record April 24; ex-div April 23.
https://seekingalpha.com/news/3560655-procter-gamble-increases-dividend-6

Campbell Soup leads food sector in blazing-hot Nielsen data

The latest Nielsen data highlights dramatically the pantry-loading effect by U.S. consumers.
Tracked channel growth by food company (dollar sales year-over-year for 4-week period ending April 4): Campbell Soup (NYSE:CPB) +68%, B&G Foods (NYSE:BGS) +66%, McCormick (NYSE:MKC) +63%, General Mills (NYSE:GIS) +63%, Kraft Heinz (NASDAQ:KHC) +50%, Flower Foods (NYSE:FLO) +48%, Post Holdings (NYSE:POST) +42%, ConAgra (NYSE:CAG) +37%, Mondelez International (NASDAQ:MDLZ) +37%, Kellogg (NYSE:K) +37%, Nestle (OTCPK:NSRGY) +33%, Danone N.A. (OTCQX:DANOY) +25%, Dean Foods (NYSE:DF) +13%, Hershey +11%, Simply Good Foods (NASDAQ:SMPL) +0.7%.
All the food companies saw sales cool off during the last week of the tracking period from the pace of the three weeks prior.
Wells Fargo’s John Baumgartner on the sector: “Significant uncertainty abounds re: COVID’s prolonged impact but we expect Food to outperform vs. S&P and Staples peers given: (1) limited intl. supply chain risks vs. other S&P sectors, (2) benefits from increased at-home consumption, (3) defensive rotation/Food’s historical outperformance vs. S&P 500/Staples peers during economic dislocations.”
https://seekingalpha.com/news/3560622-campbell-soup-leads-food-sector-in-blazing-hot-nielsen-data

Johnson & Johnson EPS beats by $0.30, beats on revenue

Johnson & Johnson: Q1 Non-GAAP EPS of $2.30 beats by $0.30; GAAP EPS of $2.17 beats by $0.74.
Revenue of $20.69B (+3.3% Y/Y) beats by $1.21B.
Shares +1.95% PM.
https://seekingalpha.com/news/3560379-johnson-johnson-eps-beats-0_30-beats-on-revenue

Johnson & Johnson raises dividend by 6%

Johnson & Johnson (NYSE:JNJ) declares $1.01/share quarterly dividend, 6.3% increase from prior dividend of $0.95.
Payable June 9; for shareholders of record May 26; ex-div May 22.
https://seekingalpha.com/news/3560377-johnson-johnson-raises-dividend-6